CMSV USE CASES
Learn how the CMSV tool can help you.
Subnational estimates of contraceptive utilization
A non-profit contraceptive service provision organization has recently received additional funding to expand its subsidized contraceptive services from Nairobi County to another county in Kenya, with the goal of increasing contraceptive service coverage and improving modern contraceptive use among women with an unmet need. While the organization can identify the next most underserved county, it also needs to consider the number of existing contraceptive users, those with an unmet contraceptive need, and the density of private sector clinics in the area. Furthermore, the organization needs to identify a sub-county where a new clinic should be located within that county.
Using the Subnational Market Size Estimator at the county level, the organization can easily identify which counties have the lowest private clinic density while also showing a relatively strong reliance on the public sector for short-term contraceptives. Using the Subnational Market Size Estimator at the sub-county level, the organization can then pinpoint a specific sub-county within their target county that has a large number of modern contraceptive users and women with an unmet contraceptive need, helping to ensure the new clinic is located where it can have the greatest impact.
National Private Sector Contraceptive Market Size Estimation
The government of Kenya has recently approved a new generic formulation of DMPA-SC, opening the door for distributors to enter a growing market. A contraceptive wholesaler looking to introduce this generic product wants to understand where it can quickly gain market penetration and develop a strategy for scaling up demand over time.
Using the National Private Sector Contraceptive Market Size Estimation, the wholesaler can first assess the current size of the private sector DMPA-SC market to establish a baseline and identify the overall opportunity. By then adjusting the DMPA-SC growth parameter, the wholesaler can model what share of the market the new generic product could realistically capture, and what that would mean in terms of annual unit volumes and market value.
To identify where to prioritize initial distribution efforts, the wholesaler can turn to the Subnational Estimates of Contraceptive Utilization. At the county level, it can identify counties with a high number of current private sector injectable users, as well as public sector injectable users who are estimated to be able to pay for their method from a private source, together painting a picture of both the existing market and the addressable growth opportunity. At the sub-county level, the wholesaler can then drill down further to identify specific areas with the highest concentrations of current private sector DMPA-SC users, allowing it to focus its initial rollout where uptake is most likely. With this evidence in hand, the wholesaler is well positioned to engage its affiliated service providers, align on a phased distribution strategy, and build the case for scaling up demand across the country.
CMSV
HOME
INTERPRETATION
The CMSV provides estimates of two different types of contraceptive market size: 1) subnational region and district level users, and 2) national level private sector users, volume, and value of contraceptives.
READ MOREMETHODOLOGY
Using nationally representative surveys, routine health service data, and high-resolution population data, the subnational market size estimation serves to illustrate the distribution of contraceptive users and those with contraceptive needs.
READ MOREEXAMPLE USE CASES
How can policy makers, private sector actors, donors, non-governmental organizations, advocates, and researchers use the CMSV?
READ MOREContact us to learn how Metrics for Management can help you use targeted, accurate, and measurable data to expand and improve your services.
GET IN TOUCHAIMS Partners
The CMSV is a product of the Advancing Injectable Markets for Sustainability (AIMS) project which is led by PATH in partnership with the Africa Resource Centre, Health Systems Insight, Metrics for Management, and Solina Centre for International Development and Research. Dedicated to improving women's choice and access to injectable contraception, AIMS is creating a sustainable market for DMPA-SC and self-injection, ensuring balanced supply and demand, with robust public- and private-sector access to contraceptive injectables for women living in low- and middle-income countries. For more www.FPoptions.org | FPoptions@path.org.
Metrics for Management © 2026 |
in


